nach oben

Erschienen in:

01.08.2010 | Original Paper

High HIV Prevalence, Suboptimal HIV Testing, and Low Knowledge of HIV-Positive Serostatus Among Injection Drug Users in St. Petersburg, Russia

verfasst von: Linda M. Niccolai, Olga V. Toussova, Sergei V. Verevochkin, Russell Barbour, Robert Heimer, Andrei P. Kozlov

Erschienen in: AIDS and Behavior | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this analysis was to estimate human immunodeficiency virus (HIV) prevalence and testing patterns among injection drug users (IDUs) in St. Petersburg, Russia. HIV prevalence among 387 IDUs in the sample was 50%. Correlates of HIV-positive serostatus included unemployment, recent unsafe injections, and history/current sexually transmitted infection. Seventy-six percent had been HIV tested, but only 22% of those who did not report HIV-positive serostatus had been tested in the past 12 months and received their test result. Correlates of this measure included recent doctor visit and having been in prison or jail among men. Among the 193 HIV-infected participants, 36% were aware of their HIV-positive serostatus. HIV prevalence is high and continuing to increase in this population. Adequate coverage of HIV testing has not been achieved, resulting in poor knowledge of positive serostatus. Efforts are needed to better understand motivating and deterring factors for HIV testing in this setting.

Abdala, N., Carney, J. M., Durante, A. J., Klimov, N., Ostrovski, D., Somlai, A. M., et al. (2003). Estimating the prevalence of syringe-borne and sexually transmitted diseases among injection drug users in St. Petersburg, Russia. International Journal of STD and AIDS, 14, 697–703. doi:10.1258/095646203322387965.CrossRefPubMed

AIDS Foundation East-West. (2007). Officially registered HIV cases in Russian Federation 1 January 1987–31 May 2007 as reported by the Russian Federal AIDS Center. Available at http://www.afew.org. Accessed 29 September 2008

Balabanova, Y., Coker, R., Atun, R. A., & Drobniewski, F. (2006). Stigma and HIV infection in Russia. AIDS Care, 18, 846–852. doi:10.1080/09540120600643641.CrossRefPubMed

Crepaz, N., Lyles, C. M., Wolitski, R. J., Passin, W. F., Rama, S. M., Herbst, J. H., et al. (2006). Do prevention interventions reduce HIV risk behaviors among people living with HIV? A metanalytic review of controlled trials. AIDS (London, England), 20, 143–157. doi:10.1097/01.aids.0000196166.48518.a0.

Crepaz, N., & Marks, G. (2002). Towards an understanding of sexual risk behavior in people living with HIV: A review of social, psychological, and medical findings. AIDS (London, England), 16, 135–149. doi:10.1097/00002030-200201250-00002.

Des Jarlais, D. C., Perlis, T., Arasteh, K., Hagan, H., Milliken, J., Braine, N., et al. (2004). “Informed altruism” and “partner restriction” in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990–2001. Journal of Acquired Immune Deficiency Syndromes, 35, 158–166. doi:10.1097/00126334-200402010-00010.CrossRefPubMed

Heckathorn, D. D. (1997). Respondent-driven sampling: A new approach to the study of hidden populations. Social Problems, 44, 174–199. doi:10.1525/sp.1997.44.2.03x0221m.CrossRef

Heckathorn, D. D. (2002). Respondent-driven sampling II: Deriving valid population estimates from chain referral samples of hidden populations. Social Problems, 49, 11–34. doi:10.1525/sp.2002.49.1.11.CrossRef

Heckathorn, D. D. (2007). Extensions of respondent-driven sampling: Analyzing continuous variables and controlling for differential recruitment. Sociological Methodology, 37, 151–208. doi:10.1111/j.1467-9531.2007.00188.x.CrossRef

Heimer, R., Grau, L. E., Curtin, E., Khoshnood, K., & Singer, M. (2007). Assessment of HIV testing of urban injection drug users: Implications for expansion of HIV testing and prevention efforts. American Journal of Public Health, 97, 110–116. doi:10.2105/AJPH.2005.078105.CrossRefPubMed

Janssen, R. S., Holtgrave, D. R., & Valdiserri, R. O. (2001). The serostatus approach to fighting the HIV epidemic: prevention strategies for infected individuals. American Journal of Public Health, 91, 1019–1024.CrossRefPubMed

Lowndes, C. M., Renton, A., Alary, M., Rhodes, T., Garnett, G., & Stimson, G. (2003). Conditions for widespread heterosexual spread of HIV in the Russian Federation: Implications for research, monitoring and prevention. The International Journal on Drug Policy, 14, 45–62. doi:10.1016/S0955-3959(02)00208-6.CrossRef

Marks, G., Crepaz, N., Senterfitt, J. W., & Janssen, R. S. (2005). Meta-analysis of high-risk sexual behaviors in persons aware and unaware they are infected with HIV in the United States. Journal of Acquired Immune Deficiency Syndromes, 39, 446–453. doi:10.1097/01.qai.0000151079.33935.79.CrossRefPubMed

Rhodes, T., Lowndes, C. M., Judd, A., Mikhailova, L. A., Sarang, A., Rylkov, A., et al. (2002). Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia. AIDS (London, England), 16, F25–F31. doi:10.1097/00002030-200209060-00002.

Rhodes, T., Platt, L., Maximova, S., Koshkina, E., Latishevskaya, N., Hickman, M., et al. (2006). Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: A multi-city study. Addiction (Abingdon, England), 101, 252–266. doi:10.1111/j.1360-0443.2006.01317.x.

Shaboltas, A. V., Toussova, O. V., Hoffman, I. F., Heimer, R., Verevochkin, S. V., Ryder, R. W., et al. (2006). HIV prevalence, social demographic and behavioral correlates and recruitment methods among injection drug users in St. Petersburg, Russia. Journal of Acquired Immununodeficiency Syndromes, 41, 657–663.

United Nations Joint Program on HIV/AIDS. (2004). UNAIDS/WHO policy statement on HIV testing.

World Health Organization. (2002). WHO consultation on increasing access to HIV testing and counseling.

World Health Organization. (2005). Russian Federation: Summary country profile for HIV/AIDS treatment scale-up.

World Health Organization. (2006). Epidemiologic fact sheet 2006 Russian Federation.

Titel: High HIV Prevalence, Suboptimal HIV Testing, and Low Knowledge of HIV-Positive Serostatus Among Injection Drug Users in St. Petersburg, Russia
verfasst von: Linda M. Niccolai
Olga V. Toussova
Sergei V. Verevochkin
Russell Barbour
Robert Heimer
Andrei P. Kozlov
Publikationsdatum: 01.08.2010
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 4/2010
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-008-9469-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2010

Numeracy Skills Explain Racial Differences in HIV Medication Management

The Male-to-Female Ratio and Multiple Sexual Partners: Multilevel Analysis with Patients from an STD Clinic

Correlates of HIV/STD Testing and Willingness to Test among Rural-to-Urban Migrants in China

Prevalence of HIV Infection and Prior HIV Testing among Young Men Who have Sex with Men. The Baltimore Young Men’s Survey

Unprotected Sex of Homeless Women Living in Los Angeles County: An Investigation of the Multiple Levels of Risk

The Associations of Voluntary Counseling and Testing Acceptance and the Perceived Likelihood of Being HIV-Infected Among Men with Multiple Sex Partners in a South African Township